rat VSMC |
Function assay |
5 μM |
30 mins |
Decrease in intracellular ROS level in PDGF-stimulated rat VSMC at 5 uM pretreated with compound for 30 mins measured after up to 23 hrs of post stimulation using H2DCF by flow cytometric analysis |
21265554 |
rat PC12 cells |
Function assay |
2.5 μM |
3 h |
Neuroprotective activity against H2O2-induced damage in rat PC12 cells assessed as cell viability at 2.5 uM preincubated for 3 hrs followed by H2O2 challenge measured after 5 hrs by MTT assay |
24697335 |
mouse RAW264.7 cells |
Function assay |
|
24 h |
Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells assessed as nitrite accumulation administered 1 hr before LPS challenge and measured after 24 hrs by Griess reagent assay, EC50=0.193 μM |
18667320 |
mouse 26-L5 cells |
Proliferation assay |
|
72 h |
Antiproliferative activity against mouse 26-L5 cells after 72 hrs by MTT assay, EC50=0.3 μM |
12027739 |
human HeLa cells |
Proliferation assay |
|
72 h |
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay, EC50=2.36 μM |
12027739 |
mouse J774.1 cells |
Function assay |
|
24 h |
Inhibition of LPS-induced NO production in mouse J774.1 cells after 24 hrs by Griess reagent assay, IC50=4.8 μM |
15974608 |
human LNCAP cells |
Function assay |
|
24 h |
Antiandrogenic activity in human LNCAP cells assessed as reduction in DHT-stimulated PSA release after 24 hrs by ELISA, IC50=6.2 nM |
24080105 |
mouse BV2 cells |
Function assay |
|
24 h |
Inhibition of nitric oxide production in LPS-stimulated mouse BV2 cells treated 3 hrs before LPS addition measured after 24 hrs by Griess assay, IC50=6.4 μM |
23870700 |
mouse B16-BL6 cells |
Proliferation assay |
|
72 h |
Antiproliferative activity against mouse B16-BL6 cells after 72 hrs by MTT assay, EC50=6.79 μM |
12027739 |
HUVEC cells |
Cytotoxic assay |
|
18 h |
Cytoprotective activity against H2O2-induced oxidative stress in HUVEC cells after 18 hrs by Cell-Titer Blue assay |
20598894 |
human HT1080 cells |
Proliferation assay |
|
72 h |
Antiproliferative activity against human HT1080 cells after 72 hrs by MTT assay, EC50=9.5 μM |
12027739 |
human HL60 cells |
Cytotoxic assay |
|
72 h |
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay, IC50=9.8 μM |
20673727 |
human LS 174T cells |
Cytotoxic assay |
|
72 h |
Cytotoxicity against human LS 174T cells after 72 hrs by MTT assay, IC60=9.9 μM |
20673727 |
human Bel7404 cells |
Cytotoxic assay |
|
72 h |
Cytotoxicity against human Bel7404 cells after 72 hrs by MTT assay, IC50=14.5 μM |
20673727 |
human BGC823 cells |
Cytotoxic assay |
|
72 h |
Cytotoxicity against human BGC823 cells after 72 hrs by MTT assay, IC50=19.3 μM |
20673727 |
human HO8910 cells |
Cytotoxic assay |
|
72 h |
Cytotoxicity against human HO8910 cells after 72 hrs by MTT assay, IC50=25.5 μM |
20673727 |
human A549 cells |
Cytotoxic assay |
|
72 h |
Cytotoxicity against human A549 cells after 72 hrs by MTT assay, IC50=26.8 μM |
20673727 |
human LNCAP cells |
Cytotoxic assay |
|
24 h |
Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs by WST-1 assay, IC50=33.7 μM |
24080105 |
human ECA109 cells |
Cytotoxic assay |
|
72 h |
Cytotoxicity against human ECA109 cells after 72 hrs by MTT assay, IC50=42.6 μM |
20673727 |
human KB cells |
Cytotoxic assay |
|
72 h |
Cytotoxicity against human KB cells after 72 hrs by MTT assay, IC50=45.2 μM |
20673727 |
human K562 cells |
Cytotoxic assay |
|
72 h |
Cytotoxicity against human K562 cells after 72 hrs by MTT assay, IC50=46 μM |
20673727 |
human Bewo cells |
Function assay |
|
|
Antitumor activity against human Bewo cells assessed as inhibition of cell growth by MTT assay, IC50=2.96 μM |
25160837 |
human Bel7402 cells |
Cytotoxic assay |
|
|
Cytotoxicity against human Bel7402 cells by MTT assay, IC50=5.5 μM |
18952420 |
human SGC7901 cells |
Function assay |
|
|
Antitumor activity against human SGC7901 cells assessed as inhibition of cell growth by MTT assay, IC50=14.26 μM |
25160837 |
human MCF7 cells |
Cytotoxic assay |
|
|
Cytotoxicity against human MCF7 cells by MTT assay, IC50=26.7 μM |
18952420 |
human HeLa cells |
Function assay |
|
|
Antitumor activity against human HeLa cells assessed as inhibition of cell growth by MTT assay, IC50=37.98 μM |
25160837 |
human HepG2 cells |
Function assay |
|
|
Antitumor activity against human HepG2 cells assessed as inhibition of cell growth by MTT assay, IC50=40.87 μM |
25160837 |
human BCG823 cells |
Cytotoxic assay |
|
|
Cytotoxicity against human BCG823 cells by MTT assay, IC50=44.6 μM |
18952420 |